Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 4, 2014, Pages 883-890

  ͆wierczyńska Krępa, Monika ^a   Sanak, Marek ^b   Bochenek, Grazyna ^b   Stręk, Paweł ^b   Ćmiel, Adam ^c   Gielicz, Anna ^b   Plutecka, Hanna ^b   Szczeklik, Andrzej ^b   Nizankowska Mogilnicka, Ewa ^b  

^a Medex   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Aspirin induced asthma; aspirin tolerant asthma; oral aspirin desensitization

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; CORTICOSTEROID; LEUKOTRIENE E4; PLACEBO; ALLERGEN; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA;

ADOLESCENT; ADULT; ARTICLE; ASPIRIN DESENSITIZATION; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN TOLERANT ASTHMA; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DESENSITIZATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DYSPEPSIA; EOSINOPHILIA; FEMALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NASAL SYMPTOM SINO NASAL OUTCOME TEST20; NOSE POLYP; PEAK EXPIRATORY FLOW; PEAK FLOWMETER; PEAK NASAL INSPIRATORY FLOW; PILOT STUDY; PROSTAGLANDIN BLOOD LEVEL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RASH; SPIROMETER; SPIROMETRY; TREATMENT RESPONSE; AGED; ASTHMA, ASPIRIN-INDUCED; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; EOSINOPHIL; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; NASAL POLYPS; ORAL DRUG ADMINISTRATION; PROCEDURES; RHINITIS; SINUSITIS; TREATMENT OUTCOME; URINE;

ADMINISTRATION, ORAL; ADULT; AGED; ALLERGENS; ASPIRIN; ASTHMA; ASTHMA, ASPIRIN-INDUCED; CHRONIC DISEASE; DESENSITIZATION, IMMUNOLOGIC; DINOPROST; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; NASAL POLYPS; PILOT PROJECTS; PROSTAGLANDIN D2; RHINITIS; SINUSITIS; SPIROMETRY; TREATMENT OUTCOME;

EID: 84908133226     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.02.041     Document Type: Article

References (49)

1. A. Szczeklik, E. Niżankowska-Mogilnicka, and M. Sanak Hypersensitivity to aspirin and non-steroidal anti-inflammatory drugs N.F. Adkinson Jr. B.S. Bochner, W.W. Busse, S.T. Holgate, R.F. Lemanske Jr. F.E.R. Simons, Middleton's allergy: principles and practice 2009 Mosby New York 1227 1240
2. T.M. Laidlaw, and J.A. Boyce Pathogenesis of aspirin-exacerbated respiratory disease and reactions Immunol Allergy Clin North Am 33 2013 195 210
3. A.A. White, and D.D. Stevenson Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization Semin Respir Crit Care Med 33 2012 588 594
4. M.L. Kowalski, J.S. Makowska, M. Blanca, S. Bavbek, G. Bochenek, and J. Bousquet Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA Allergy 66 2011 818 829
5. R.U. Lee, and D.D. Stevenson Aspirin-exacerbated respiratory disease: evaluation and management Allergy Asthma Immunol Res 3 2011 3 10
6. J.E. Chang, W. Chin, and R. Simon Aspirin-sensitive asthma and upper airway diseases Am J Rhinol Allergy 26 2012 27 30
7. R. Pezato, M. ͆wierczyńska-Krępa, E. Niżankowska-Mogilnicka, L. Derycke, C. Bachert, and C.A. Pérez-Novo Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis Allergy 67 2012 1347 1356
8. E. Macy, J.A. Bernstein, M.C. Castells, S.M. Gawchik, T.H. Lee, and R.A. Settipane Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper Ann Allergy Asthma Immunol 98 2007 172 174
9. A.N. Williams, and K.M. Woessner The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis Curr Allergy Asthma Rep 8 2008 245 252
10. L. Klimek, and O. Pfaar Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin North Am 29 2009 669 675
11. R.G. Moebus, and J.K. Han Immunomodulatory treatments for aspirin exacerbated respiratory disease Am J Rhinol Allergy 26 2012 134 140
12. G. Cortellini, S. Testi, M. Severino, T. Chechi, M.L. Iorno, and A. Santucci Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach Eur Ann Allergy Clin Immunol 44 2012 160 162
13. J.J. Xu, L. Sowerby, and B.W. Rotenberg Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter's triad): a systematic review of the literature Int Forum Allergy Rhinol 3 2013 915 920
14. G. Patriarca, P. Bellioni, E. Nucera, D. Schiavino, G. Papa, and G. Schinco Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis Ann Allergy 67 1991 588 592
15. E. Nucera, D. Schiavino, A. Milani, M. Del Ninno, C. Misuraca, and A. Buonomo Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies Thorax 55 2000 75 78
16. A.R. Sousa, A. Parkih, G. Scadding, C.J. Corrigan, and T.H. Lee Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis N Engl J Med 347 2002 1493 1499
17. J. Gosepath, D. Schäfer, and W.J. Mann Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day Laryngorhinootologie 81 2002 732 738
18. A.A. Parikh, and G.K. Scadding Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial Laryngoscope 115 2005 1385 1390
19. N. Ogata, Y. Darby, and G. Scadding Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma J Laryngol Otol 121 2007 1156 1160
20. E. Niżankowska-Mogilnicka, G. Bochenek, L. Mastalerz, M. ͆wierczyńska, C. Picado, and G. Scadding EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity Allergy 62 2007 1111 1118
21. A. Rozsasi, D. Polzehl, T. Deutschle, E. Smith, K. Wiesmiller, and H. Riechelmann Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily Allergy 63 2008 1228 1234
22. R.K. Katial, M. Strand, T. Prasertsuntarasai, R. Leung, W. Zheng, and R. Alam The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases J Allergy Clin Immunol 126 2010 738 744
23. B. Forer, S. Kivity, J. Sade, and R. Landsberg Aspirin desensitization for ASA triad patients - prospective study of the rhinologist's perspective Rhinology 49 2011 95 99
24. M. Havel, L. Ertl, F. Braunschweig, S. Markmann, A. Leunig, and F. Gamarra Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad Arch Otorhinolaryngol 270 2012 571 578
25. W.W. Pleskow, D.D. Stevenson, D.A. Mathison, R.A. Simon, M. Schatz, and R.S. Zieger Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period J Allergy Clin Immunol 69 1982 11 19
26. D.D. Stevenson, W.W. Pleskow, R.A. Simon, D.A. Mathison, W.R. Lumry, and M. Schatz Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin J Allergy Clin Immunol 73 1984 500 507
27. J.A. Sweet, D.D. Stevenson, R.A. Simon, and D.A. Mathison Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma J Allergy Clin Immunol 86 1990 59 65
28. J.V. Bosso, L.B. Schwartz, and D.D. Stevenson Tryptase and histamine release during aspirin-induced respiratory reactions J Allergy Clin Immunol 88 1991 830 837
29. U.R. Juergens, S.C. Christiansen, D.D. Stevenson, and B.L. Zuraw Inhibition of monocyte leukotriene B4 production following aspirin desensitization J Allergy Clin Immunol 96 1995 148 156
30. S.M.S. Nasser, M. Patel, G.S. Bell, and T.H. Lee The effect of aspirin desensitization on urinary leukotriene E4 concentration in aspirin-sensitive asthma Am J Respir Crit Care Med 151 1995 1326 1330
31. D.D. Stevenson, M.A. Hankammer, D.A. Mathison, S.C. Christiansen, and R.A. Simon Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies J Allergy Clin Immunol 98 1996 751 758
32. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 111 2003 180 186
33. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 90 2003 338 341
34. D. Stevenson, and R.A. Simon Selection of patients for aspirin desensitization J Allergy Clin Immunol 116 2006 801 804
35. R.U. Lee, A.A. White, D. Ding, A.B. Dursun, K.M. Woessner, and R.A. Simon Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 105 2010 130 135
36. S. Shah, and V. Mehta Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management Postgrad Med J 88 2012 73 78
37. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2012. Available at: www.ginaasthma.org. Accessed December 2013.
38. W.J. Fokkens, V.J. Lund, J. Mullol, C. Bachert, I. Alobid, and F. Baroody European position paper on rhinosinusitis and nasal polyps 2012 Rhinol Suppl 3 2012 1 298
39. V.J. Lund, and M.D. Kennedy Staging for rhinosinusitis Otolaryngol Head Neck Surg 117 1997 35 40
40. M. Kumlin Measurement of leukotrienes in humans Am J Respir Crit Care Med 161 2000 102 106
41. G. Bochenek, E. Niżankowska, A. Gielicz, M. ͆wierczyńska, and A. Szczeklik Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma Thorax 59 2004 459 464
42. J.W. Steinke, S.C. Payne, and L. Borish Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization J Allergy (Cairo) 2012 2012 182090
43. T. Burnett, R. Katial, and R. Alam Mechanisms of aspirin desensitization Immunol Allergy Clin North Am 33 2013 223 236
44. M. Swierczynska, E. Nizankowska-Mogilnicka, J. Zarychta, A. Gielicz, and A. Szczeklik Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis J Allergy Clin Immunol 112 2003 995 1001
45. J.P. Arm, S.P. O'Hickey, B.W. Spur, and T.H. Lee Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma Am Rev Respir Dis 140 1989 148 153
46. T.M. Laidlaw, M.S. Kidder, N. Bhattacharyya, W. Xing, S. Shen, and G.L. Milne Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes Blood 119 2012 3790 3798
47. G. Bochenek, K. Nagraba, E. Niżankowska, and A. Szczeklik A controlled study of 9alpha,11beta-PGF2 (a PGD2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge J Allergy Clin Immunol 111 2003 743 749
48. A.A. White, and D.D. Stevenson Side effects from daily aspirin treatment in patients with AERD: identification and management Allergy Asthma Proc 32 2011 333 334
49. T.W. Baker, and J.M. Quinn Aspirin therapy in aspirin-exacerbated respiratory disease: a risk-benefit analysis for the practicing allergist Allergy Asthma Proc 32 2011 335 340